Report - Entdeckung der pan-CDK Inhibitoren · Ergebnisse Phase I Testung 11 Medicinal Chemistry Berlin 2018 N HN N N H Br S OH NH 2 O O HCl Dosis-Eskalationsstudie in Patienten (15 mg/Tag

Please pass captcha verification before submit form